Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,111.63
(
-0.38%
)
US TECH 100
26,338.00
(
0.14%
)
Dow Jones
48,791.40
(
-0.71%
)
Brent Oil
110.25
(
5.59%
)
Bitcoin
75,519.99
(
-1.08%
)
News Focus
News Focus
Post# of 257465
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122905
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: RockRat post# 211864

Wednesday, 06/14/2017 10:27:41 AM

Wednesday, June 14, 2017 10:27:41 AM

Post# of 257465
(ADXS)—For HPV-associated cancers (cervical, H&N), AZN is advancing Durvalumab combinations with INO's cancer vaccine (#msg-131236136, #msg-132005083), which was a pretty good tell that AZN had soured on AXAL.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today